Weight loss methods for longer life with metabolic syndrome
Part of Hormones & metabolism clinical trials.
This trial tests weight loss methods in people with type 2 diabetes, high blood pressure, and excess weight. It aims to see if losing 15-20% of body weight can help people live longer and healthier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 2 diabetes for at least 3 years and are using medication (including insulin) to control it.
- You are between 35 and 55 years old.
- You have a body mass index (BMI) of 27 or higher — this is a measure of weight relative to height, and the cutoff is the same for Asian ethnicity.
- You are currently taking medication for high blood pressure.
- You are able to lose 15-20% of your body weight and stick with the program for 24 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a lifestyle program combined with two medications (semaglutide and dapagliflozin) to help people with metabolic syndrome lose weight and improve their health. It may be an option if you are an adult with a BMI of 27 to 45 and have metabolic syndrome.
This early-phase trial tests whether an SGLT2 drug can reduce inflammation in belly fat and improve blood vessel function. It may help people with metabolic syndrome prepare for (and potentially benefit around) planned gastric bypass or sleeve surgery.
This trial tests if empagliflozin, a medication typically used for diabetes, can help people with metabolic syndrome (a cluster of conditions like large waist size, high blood sugar, and high blood pressure). It may improve health and reduce the risk of heart disease.
This study tests if combining intermittent fasting, calorie reduction, and physical activity can help manage metabolic syndrome (a group of risk factors that increase your chance of heart disease, stroke, and diabetes). If you have at least three of five specific health issues (like belly fat, high blood pressure, or high blood sugar) and are an adult aged 18 or older, you may be able to join.
This study tests a new medicine called NNC0487-0111 to see how well it helps people with excess body weight and type 2 diabetes lose weight, compared to another medicine called semaglutide. It may be an option if you have type 2 diabetes and are looking to manage your weight.
This study tests two different medicines (empagliflozin or semaglutide) added to your usual insulin to see if they help with blood sugar control and weight loss in people with type 1 diabetes who are overweight or have obesity. It may be a good fit if your diabetes is not well controlled with insulin injections alone.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.